New products in the Life Sciences industry fail to win a significant spot in the market at an alarming rate. And since the costs of bringing a product to market are extremely high – the risk of any missteps can be devastating. Therefore, it makes sense for biotech, pharma, and medical device companies to use every tool at their disposal to ensure they are as prepared as possible. Unfortunately, many companies overlook one of the most versatile tools available to them – their ERP solution.
ERP systems like MAXLife can help companies by providing insight into costs and operational efficiencies that enable you to improve margins and increase overall corporate value. Using the capabilities within the ERP system, your team can work to streamline processes, standardizing across products, facilities and CMOs (contract manufacturing operator) to help manage growth during the critical ramp up period without letting headcount get out of control.
You have enough on your plate as it is bringing your product to market without worrying about setting up an entire data center, hiring an IT staff and taking steps to ensure your systems are validated and your cloud environments are qualified. Saving the capital you would otherwise spend on IT infrastructure for product commercialization can make a huge difference in time to market by allowing you to invest in operational infrastructure, clinical trials or even marketing your new design.
Use the registration form on this page to access the white paper: Using ERP to Prepare for Commercialization.